283 related articles for article (PubMed ID: 12963911)
1. Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians.
Natta R; Somsak T; Wisuttida T; Laor L
J Am Acad Dermatol; 2003 Sep; 49(3):473-6. PubMed ID: 12963911
[TBL] [Abstract][Full Text] [Related]
2. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
3. Treatment of vitiligo with broadband ultraviolet B and vitamins.
Don P; Iuga A; Dacko A; Hardick K
Int J Dermatol; 2006 Jan; 45(1):63-5. PubMed ID: 16426381
[TBL] [Abstract][Full Text] [Related]
4. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
Parsad D; Kanwar AJ; Kumar B
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
[TBL] [Abstract][Full Text] [Related]
5. Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study.
Sapam R; Agrawal S; Dhali TK
Int J Dermatol; 2012 Sep; 51(9):1107-15. PubMed ID: 22909369
[TBL] [Abstract][Full Text] [Related]
6. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z
J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
[TBL] [Abstract][Full Text] [Related]
7. Psoralen and narrowband UVB combination provides higher efficacy in treating vitiligo compared with narrowband UVB alone: A randomised clinical trial.
Zabolinejad N; Maleki M; Salehi M; Ashrafi Z; Molkara S; Layegh P
Australas J Dermatol; 2020 Feb; 61(1):e65-e69. PubMed ID: 31651037
[TBL] [Abstract][Full Text] [Related]
8. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
Westerhof W; Nieuweboer-Krobotova L
Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
[TBL] [Abstract][Full Text] [Related]
9. Clinical study of repigmentation patterns with either narrow-band ultraviolet B (NBUVB) or 308 nm excimer laser treatment in Korean vitiligo patients.
Yang YS; Cho HR; Ryou JH; Lee MH
Int J Dermatol; 2010 Mar; 49(3):317-23. PubMed ID: 20465673
[TBL] [Abstract][Full Text] [Related]
10. 308-nm excimer laser for the treatment of localized vitiligo.
Taneja A; Trehan M; Taylor CR
Int J Dermatol; 2003 Aug; 42(8):658-62. PubMed ID: 12890118
[TBL] [Abstract][Full Text] [Related]
11. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.
Passeron T; Ostovari N; Zakaria W; Fontas E; Larrouy JC; Lacour JP; Ortonne JP
Arch Dermatol; 2004 Sep; 140(9):1065-9. PubMed ID: 15381545
[TBL] [Abstract][Full Text] [Related]
12. Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone.
Bansal S; Sahoo B; Garg V
Photodermatol Photoimmunol Photomed; 2013 Dec; 29(6):311-7. PubMed ID: 24118425
[TBL] [Abstract][Full Text] [Related]
13. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
Asawanonda P; Klahan SO
Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
[TBL] [Abstract][Full Text] [Related]
14. Tacalcitol: a useful adjunct to narrow-band ultraviolet-B phototherapy in vitiligo.
Sahu P; Jain VK; Aggarwal K; Kaur S; Dayal S
Photodermatol Photoimmunol Photomed; 2016 Sep; 32(5-6):262-268. PubMed ID: 27552149
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of combined oral minocycline and narrowband UVB phototherapy in vitiligo: A randomized, double-blind, placebo-controlled trial.
Charoenpongpun N; Kamanamool N; Udompataikul M; Khunkhet S; Kanokrungsee S
Dermatol Ther; 2022 Aug; 35(8):e15596. PubMed ID: 35608017
[TBL] [Abstract][Full Text] [Related]
16. Phototherapy for Vitiligo: A Systematic Review and Meta-analysis.
Bae JM; Jung HM; Hong BY; Lee JH; Choi WJ; Lee JH; Kim GM
JAMA Dermatol; 2017 Jul; 153(7):666-674. PubMed ID: 28355423
[TBL] [Abstract][Full Text] [Related]
17. Predictive Model for Response Rate to Narrowband Ultraviolet B Phototherapy in Vitiligo: A Retrospective Cohort Study of 579 Patients.
Cabrera R; Hojman L; Recule F; Sepulveda R; Delgado I
Acta Derm Venereol; 2018 Apr; 98(4):416-420. PubMed ID: 29362810
[TBL] [Abstract][Full Text] [Related]
18. Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study.
Ermis O; Alpsoy E; Cetin L; Yilmaz E
Br J Dermatol; 2001 Sep; 145(3):472-5. PubMed ID: 11531839
[TBL] [Abstract][Full Text] [Related]
19. Bath Psoralen-ultraviolet A and Narrowband Ultraviolet B Phototherapy as Initial Therapy for Early-stage Mycosis Fungoides: A Retrospective Cohort of 267 Cases at the University of Toronto.
Almohideb M; Walsh S; Walsh S; Shear N; Alhusayen R
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):604-612. PubMed ID: 28711574
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]